IRIS Accounts Production v25.1.4.42 10051596 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100515962024-03-31100515962025-03-31100515962024-04-012025-03-31100515962023-03-31100515962023-04-012024-03-31100515962024-03-3110051596ns15:EnglandWales2024-04-012025-03-3110051596ns14:PoundSterling2024-04-012025-03-3110051596ns10:Director12024-04-012025-03-3110051596ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110051596ns10:SmallEntities2024-04-012025-03-3110051596ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110051596ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110051596ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110051596ns10:FullAccounts2024-04-012025-03-311005159612024-04-012025-03-3110051596ns10:Director22024-04-012025-03-3110051596ns10:RegisteredOffice2024-04-012025-03-3110051596ns5:CurrentFinancialInstruments2025-03-3110051596ns5:CurrentFinancialInstruments2024-03-3110051596ns5:Non-currentFinancialInstruments2025-03-3110051596ns5:Non-currentFinancialInstruments2024-03-3110051596ns5:ShareCapital2025-03-3110051596ns5:ShareCapital2024-03-3110051596ns5:SharePremium2025-03-3110051596ns5:SharePremium2024-03-3110051596ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110051596ns5:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3110051596ns5:ComputerSoftware2024-04-012025-03-3110051596ns5:PlantMachinery2024-04-012025-03-3110051596ns5:IntangibleAssetsOtherThanGoodwill2024-03-3110051596ns5:IntangibleAssetsOtherThanGoodwill2025-03-3110051596ns5:IntangibleAssetsOtherThanGoodwill2024-03-3110051596ns5:PlantMachinery2024-03-3110051596ns5:PlantMachinery2025-03-3110051596ns5:PlantMachinery2024-03-3110051596ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3110051596ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110051596ns5:RetainedEarningsAccumulatedLosses2024-03-3110051596ns5:SharePremium2024-03-3110051596ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3110051596ns5:RetainedEarningsAccumulatedLosses2025-03-31
REGISTERED NUMBER: 10051596 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Tiny Medical Apps Ltd

Tiny Medical Apps Ltd (Registered number: 10051596)






Contents of the Financial Statements
for the year ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Tiny Medical Apps Ltd

Company Information
for the year ended 31 March 2025







DIRECTORS: M Bourne
G Burch





REGISTERED OFFICE: 94 Elm Drive
Hove
BN3 7JL





REGISTERED NUMBER: 10051596 (England and Wales)





ACCOUNTANTS: Simpson Accountancy Limited
Unit 6 Cherrytree Farm
Blackmore End Road
Sible Hedingham
Essex
CO9 3LZ

Tiny Medical Apps Ltd (Registered number: 10051596)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2,345 3,460
Tangible assets 5 1,369 2,420
3,714 5,880

CURRENT ASSETS
Debtors 6 449,834 209,070
Cash at bank 308,179 36,832
758,013 245,902
CREDITORS
Amounts falling due within one year 7 648,480 137,895
NET CURRENT ASSETS 109,533 108,007
TOTAL ASSETS LESS CURRENT
LIABILITIES

113,247

113,887

CREDITORS
Amounts falling due after more than one
year

8

34,410

8,782
NET ASSETS 78,837 105,105

CAPITAL AND RESERVES
Called up share capital 100 100
Share premium 9 12,850 12,850
Retained earnings 9 65,887 92,155
SHAREHOLDERS' FUNDS 78,837 105,105

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Tiny Medical Apps Ltd (Registered number: 10051596)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 July 2025 and were signed on its behalf by:





M Bourne - Director


Tiny Medical Apps Ltd (Registered number: 10051596)

Notes to the Financial Statements
for the year ended 31 March 2025

1. STATUTORY INFORMATION

Tiny Medical Apps Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Computer software is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Tiny Medical Apps Ltd (Registered number: 10051596)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 April 2024
and 31 March 2025 12,380
AMORTISATION
At 1 April 2024 8,920
Charge for year 1,115
At 31 March 2025 10,035
NET BOOK VALUE
At 31 March 2025 2,345
At 31 March 2024 3,460

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024
and 31 March 2025 5,577
DEPRECIATION
At 1 April 2024 3,157
Charge for year 1,051
At 31 March 2025 4,208
NET BOOK VALUE
At 31 March 2025 1,369
At 31 March 2024 2,420

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 449,834 209,070

Tiny Medical Apps Ltd (Registered number: 10051596)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 38,282 (1 )
Taxation and social security 197,054 48,496
Other creditors 413,144 89,400
648,480 137,895

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 6,500 8,782
Other creditors 27,910 -
34,410 8,782

9. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 April 2024 92,155 12,850 105,005
Deficit for the year (26,268 ) - (26,268 )
At 31 March 2025 65,887 12,850 78,737